Roxelyn G. Baumgartner
Papers
7
Total Citations
696
H-Index
6
About
Roxelyn G. Baumgartner is a leading figure in urologic oncology, best known for her pioneering work in comparing robotic-assisted laparoscopic prostatectomy (RALP) with traditional open radical retropubic prostatectomy (RRP) for prostate cancer. Her research has fundamentally shaped the evidence base for minimally invasive surgery, demonstrating that RALP significantly reduces postoperative pain and shortens hospital stays without compromising early oncologic control. Her landmark 2007 study comparing hospital length of stay between the two approaches has been cited over 197 times, while her prospective assessment of postoperative pain (2005) has garnered 172 citations, establishing her as a key voice in perioperative outcomes. Baumgartner also led a multi-institutional study on thromboembolic complications in laparoscopic prostatectomy (146 citations) and contributed to the development of evidence-based clinical pathways that improved care for both open and robotic procedures. Her work has directly influenced surgical practice, helping to drive the widespread adoption of robotic techniques. Through rigorous comparative effectiveness research, Baumgartner has provided the urologic community with critical data that balances surgical innovation with patient-centered outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7